Thursday, June 25, 2009
Green Tea Blocks the Anticancer Effects of Bortezomib
I really enjoy drinking green tea. Fortunately, I'm not receiving any chemotherapy right now. I hope I never have to receive chemotherapy. A recent study found that the polyphenols in green tea may block the anticancer effects in bortezomib (Velcade) by Millennium Pharmaceuticals, now part of Takeda Pharmaceuticals.
Bortezomib (Velcade) is a proteasome inhibitor that is used to treat multiple myeloma, certain lymphomas (such as mantle cell lymphoma), and other cancers. Should the consumption of green tea be a contraindication when you're being treated with Velcade? Cancer patients are often taking multiple herbs, vitamins, and other types of alternative therapies. Let's hope that the word gets around about how green tea may interact with Velcade.